In a first, FDA signs off on CellTrans' type 1 diabetes cell therapy days after industry's eyes fixated on Vertex data
Certain patients with type 1 diabetes now have an option to use cell therapy thanks to a new FDA approval.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
